A study by Cutting Edge Information found that pharmaceutical companies measure cost per patient per month to allow trials of different sizes and durations to be compared easily. This measurement also helps to illustrate the high costs associated with delays.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now